Citi's $80 Moderna Target Implies 60% Drop

Citi puts Moderna at $80, implying about 60% downside from Tuesday's close, according to a Sept. 30 note reported by CNBC. That means Citi expects the stock to lose three-fifths of its value over its forecast horizon. I see this as a valuation anchor, not a timing call — price and Citi's view remain far apart.